on Facebook
on Twitter
on YouTube
Document Information
Product Liability and the Economics of Pharmaceuticals and Medical Devices
This study examined the economic effects of product liability on firms producing drugs and medical devices. The analysis drew on empirical information from a wide variety of sources, simulations, and interviews at three major pharmaceutical companies to examine the effects of liability on product availability, safety, effectiveness, and innovation. The study found that the liability system enhances the economic contributions of these industries in some ways — for example, encouraging them to invest in safer designs for medical devices; undermines them in some — for example, causing companies to withdraw products that the medical community generally believe were beneficial; and has mixed effects in others — for example, in the areas of pricing and innovation. The effects are industry specific, and the perceptions of firm decision makers about the probability and consequences of liability suits must be addressed to understand both the effects of the current system and the effects of reforms. The study identified liability policy reforms that should improve economic performance: make regulatory compliance central for drugs and extensively regulated devices, specify explicit standards for behavior warranting punitive damages, and improve procedures for weighing scientific evidence about the cause of injury.
See Also:
Support RAND Research — Buy This Product!
Paperback Cover Price: $55.00
Discounted Web Price: $49.50
Pages: 266
ISBN/EAN: 0-8330-1450-1
Free, downloadable PDF file(s) are available below.
RAND makes an electronic version of this document available for free as a public service. If you find this information valuable, please consider purchasing a paper copy of the full document to help support RAND research.
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
The report was a product of the RAND Corporation from 1948 to 1993 that represented the principal publication documenting and transmitting RAND's major research findings and final research.
This research in the public interest was supported by RAND, using discretionary funds made possible by the generosity of RAND's donors, the fees earned on client-funded research, and independent research and development (IR&D) funds provided by the Department of Defense.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit research organization providing objective analysis and effective solutions that address the challenges facing the public and private sectors around the world. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
* RAND research is conducted across divisions, centers, and projects; these organizational components are represented in the "Related RAND Divisions" section above.
Top
RAND® is a registered trademark. Copyright © 1994-2009 RAND Corporation. Last Modified: December 07, 2007 